LENSAR Operating Margin 2019-2025 | LNSR

Current and historical operating margin for LENSAR (LNSR) over the last 10 years. The current operating profit margin for LENSAR as of September 30, 2025 is -87.12%.
LENSAR Operating Margin Historical Data
Date TTM Revenue TTM Operating Income Operating Margin
2025-09-30 $0.06B $-0.02B -35.59%
2025-06-30 $0.06B $-0.01B -23.73%
2025-03-31 $0.06B $-0.01B -22.41%
2024-12-31 $0.06B $-0.01B -18.18%
2024-09-30 $0.05B $-0.01B -24.00%
2024-06-30 $0.05B $-0.01B -28.26%
2024-03-31 $0.05B $-0.01B -24.44%
2023-12-31 $0.04B $-0.01B -28.57%
2023-09-30 $0.04B $-0.01B -30.00%
2023-06-30 $0.04B $-0.01B -36.84%
2023-03-31 $0.03B $-0.02B -52.94%
2022-12-31 $0.04B $-0.02B -60.00%
2022-09-30 $0.04B $-0.02B -61.11%
2022-06-30 $0.04B $-0.02B -66.67%
2022-03-31 $0.04B $-0.02B -58.33%
2021-12-31 $0.03B $-0.02B -55.88%
2021-09-30 $0.03B $-0.02B -70.97%
2021-06-30 $0.03B $-0.02B -70.00%
2021-03-31 $0.03B $-0.02B -77.78%
2020-12-31 $0.03B $-0.02B -73.08%
2020-06-30 $0.02B $-0.01B -63.16%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.143B $0.053B
LENSAR Inc. is a commercial-stage medical device company. It focuses on designing, developing and marketing an advanced femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. LENSAR Inc. is based in Orlando, Florida.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $232.567B 27.63
Intuitive Surgical (ISRG) United States $189.075B 73.97
IDEXX Laboratories (IDXX) United States $54.780B 54.40
Edwards Lifesciences (EW) United States $48.432B 32.47
IQVIA Holdings (IQV) United States $39.797B 22.19
Alcon (ALC) Switzerland $39.104B 26.35
Mettler-Toledo (MTD) United States $28.673B 33.55
DexCom (DXCM) United States $27.586B 38.03
STERIS (STE) Ireland $25.321B 26.14
Waters (WAT) United States $22.858B 30.23
Coloplast (CLPBY) Denmark $18.998B 32.42
Hologic (HOLX) United States $16.742B 17.59
SONOVA HOLDING (SONVY) Switzerland $16.345B 0.00
Penumbra (PEN) United States $13.920B 97.92
Globus Medical (GMED) United States $12.440B 26.11
Masimo (MASI) United States $7.665B 24.56
Glaukos (GKOS) United States $7.090B 0.00
Sysmex ADR (SSMXY) Japan $6.188B 19.66
TransMedics (TMDX) United States $4.850B 57.46
Teleflex (TFX) United States $4.434B 7.07
LivaNova (LIVN) United Kingdom $3.436B 18.56
Veracyte (VCYT) United States $3.296B 37.56
Integer Holdings (ITGR) United States $2.984B 14.01
Alphatec Holdings (ATEC) United States $2.548B 0.00
Elekta AB (EKTAY) Sweden $2.400B 22.45
Artivion (AORT) United States $2.061B 94.59
UFP Technologies (UFPT) United States $2.023B 26.71
Nihon Kohden (NHNKY) Japan $1.955B 17.07
PROCEPT BioRobotics (PRCT) United States $1.694B 0.00
AxoGen (AXGN) United States $1.470B 0.00
Tandem Diabetes Care (TNDM) United States $1.389B 0.00
IRadimed (IRMD) United States $1.310B 62.41
OPKO Health (OPK) United States $0.990B 0.00
Pulse Biosciences (PLSE) United States $0.937B 0.00
Integra LifeSciences Holdings (IART) United States $0.935B 5.07
Beta Bionics (BBNX) United States $0.811B 0.00
SiBone (SIBN) United States $0.735B 0.00
Pacific Biosciences Of California (PACB) United States $0.713B 0.00
Tactile Systems Technology (TCMD) United States $0.671B 38.99
AVANOS MEDICAL, INC (AVNS) United States $0.573B 11.44
NeuroPace (NPCE) United States $0.550B 0.00
Alpha Tau Medical (DRTS) Israel $0.548B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.540B 0.00
OrthoPediatrics (KIDS) United States $0.463B 0.00
Mesa Laboratories (MLAB) United States $0.458B 12.63
AngioDynamics (ANGO) United States $0.427B 0.00
RxSight (RXST) United States $0.397B 0.00
ClearPoint Neuro (CLPT) United States $0.395B 0.00
Delcath Systems (DCTH) United States $0.360B 59.94
Sight Sciences (SGHT) United States $0.330B 0.00
Semler Scientific (SMLR) United States $0.311B 2.32
Spectral Diagnostics (EDTXF) Canada $0.286B 0.00
Anteris Technologies Global (AVR) Australia $0.237B 0.00
908 Devices (MASS) United States $0.236B 0.00
Nano-X Imaging (NNOX) Israel $0.195B 0.00
Rapid Micro Biosystems (RPID) United States $0.195B 0.00
Inogen (INGN) United States $0.169B 0.00
Lucid Diagnostics (LUCD) United States $0.167B 0.00
Treace Medical Concepts (TMCI) United States $0.166B 0.00
CVRx (CVRX) United States $0.147B 0.00
Microbot Medical (MBOT) United States $0.140B 0.00
EDAP TMS S.A (EDAP) France $0.138B 0.00
Neuronetics (STIM) United States $0.133B 0.00
Solana (HSDT) United States $0.126B 0.00
Zomedica (ZOMDF) United States $0.119B 0.00
Hyperfine (HYPR) United States $0.117B 0.00
Accuray (ARAY) United States $0.092B 0.00
DarioHealth (DRIO) United States $0.084B 0.00
Sensus Healthcare (SRTS) United States $0.081B 0.00
Atossa Genetics (ATOS) United States $0.078B 0.00
InspireMD (NSPR) United States $0.068B 0.00
QT Imaging Holdings (QTIH) United States $0.068B 0.00
Positron (POSC) United States $0.053B 0.00
Spectral AI (MDAI) United States $0.048B 0.00
Precision Optics (POCI) United States $0.034B 0.00
Baird Medical Investment Holdings (BDMD) $0.030B 0.00
Ekso Bionics Holdings (EKSO) United States $0.022B 0.00
Envoy Medical (COCH) United States $0.019B 0.00
Vicarious Surgical (RBOT) United States $0.017B 0.00
Adagio Medical Holdings (ADGM) United States $0.013B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.013B 0.00
NexGel (NXGL) United States $0.013B 0.00
Check-Cap (MBAI) Israel $0.012B 0.00
Tenon Medical (TNON) United States $0.011B 0.00
EnVVeno Medical (NVNO) United States $0.007B 0.00
Venus Concept (VERO) Canada $0.006B 0.00
PAVmed (PAVM) United States $0.006B 0.00
Nanovibronix (NAOV) United States $0.004B 0.00
ENDRA Life Sciences (NDRA) United States $0.004B 0.00
Autonomix Medical (AMIX) United States $0.003B 0.00
Nuwellis (NUWE) United States $0.003B 0.00
ENvue Medical (FEED) United States $0.001B 0.00
Bluejay Diagnostics (BJDX) United States $0.001B 0.00
WORK Medical Technology Group (WOK) China $0.000B 0.00
Fresenius Medical Care AG KGaA (FMS) Germany $0.000B 10.15
Spinal Elements Holdings (SPEL) United States $0.000B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.000B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00